ARS Pharmaceuticals Inc (SPRY)
11.34
+0.26
(+2.35%)
USD |
NASDAQ |
Jan 07, 16:00
11.34
0.00 (0.00%)
After-Hours: 20:00
ARS Pharmaceuticals Total Liabilities (Quarterly): 16.62M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Exelixis Inc | 684.86M |
| Assembly Biosciences Inc | 74.26M |
| Protagonist Therapeutics Inc | 71.94M |
| Precision BioSciences Inc | 88.39M |
| Avidity Biosciences Inc | 137.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.60M |
| Shareholders Equity (Quarterly) | 200.98M |
| Current Ratio | 12.56 |